BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23587527)

  • 1. The characteristics of unacceptable/taboo thoughts in obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
    Compr Psychiatry; 2013 Oct; 54(7):750-7. PubMed ID: 23587527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further support for five dimensions of obsessive-compulsive symptoms.
    Brakoulias V; Starcevic V; Berle D; Sammut P; Milicevic D; Moses K; Hannan A; Martin A
    J Nerv Ment Dis; 2013 Jun; 201(6):452-9. PubMed ID: 23686154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
    Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
    J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationships between obsessive-compulsive symptom dimensions and cognitions in obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Hannan A; Martin A
    Psychiatr Q; 2014 Jun; 85(2):133-42. PubMed ID: 24142072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.
    Williams MT; Farris SG; Turkheimer EN; Franklin ME; Simpson HB; Liebowitz M; Foa EB
    J Anxiety Disord; 2014 Aug; 28(6):553-8. PubMed ID: 24983796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived parental rearing style in obsessive-compulsive disorder: relation to symptom dimensions.
    Alonso P; Menchón JM; Mataix-Cols D; Pifarré J; Urretavizcaya M; Crespo JM; Jiménez S; Vallejo G; Vallejo J
    Psychiatry Res; 2004 Jul; 127(3):267-78. PubMed ID: 15296826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Sexually Intrusive Thoughts: Parsing Unacceptable Thoughts on the Dimensional Obsessive-Compulsive Scale.
    Wetterneck CT; Siev J; Adams TG; Slimowicz JC; Smith AH
    Behav Ther; 2015 Jul; 46(4):544-56. PubMed ID: 26163717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent class analysis of obsessive-compulsive symptoms in a clinical sample.
    Atli A; Boysan M; Çetinkaya N; Bulut M; Bez Y
    Compr Psychiatry; 2014 Apr; 55(3):604-12. PubMed ID: 24262128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
    Australas Psychiatry; 2013 Apr; 21(2):117-21. PubMed ID: 23426097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test].
    Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M
    Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement.
    Deacon BJ; Abramowitz JS
    J Anxiety Disord; 2005; 19(5):573-85. PubMed ID: 15749574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
    Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
    J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom Dimensions, Smoking and Impulsiveness in Obsessive-Compulsive Disorder.
    Tan O; Taş C
    Psychiatr Danub; 2015 Dec; 27(4):397-405. PubMed ID: 26609653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fear of Self and Unacceptable Thoughts in Obsessive-Compulsive Disorder.
    Melli G; Aardema F; Moulding R
    Clin Psychol Psychother; 2016 May; 23(3):226-35. PubMed ID: 25772861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myth of the pure obsessional type in obsessive--compulsive disorder.
    Williams MT; Farris SG; Turkheimer E; Pinto A; Ozanick K; Franklin ME; Liebowitz M; Simpson HB; Foa EB
    Depress Anxiety; 2011 Jun; 28(6):495-500. PubMed ID: 21509914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics of obsessive compulsive disorder associated with high levels of schizotypy.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Hannan A; Viswasam K; Mann K
    Aust N Z J Psychiatry; 2014 Sep; 48(9):852-60. PubMed ID: 24740253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorder.
    Faragian S; Pashinian A; Fuchs C; Poyurovsky M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1009-12. PubMed ID: 19447155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom dimensions in obsessive-compulsive disorder: differences in distress, interference, appraisals and neutralizing strategies.
    García-Soriano G; Belloch A
    J Behav Ther Exp Psychiatry; 2013 Dec; 44(4):441-8. PubMed ID: 23792753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.